← Evidence map

ArticlePharmacology research & perspectives2024

Corrigendum to "Intestinal, portal, and peripheral profiles of daikenchuto (TU-100)'s active ingredients after oral administration".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38752488